Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

aedes_aegypti_mosquito

New research supports association between Zika virus and microcephaly

March 16, 2016 Medical Communications, Research and Development Lancet, Zika virus, french polynesia, microcephaly, outbreak

Using data from the 2013-14 outbreak of Zika virus in French Polynesia, new research in The Lancet has further supported …
News
bruce_roberts_vedanta

PureTech’s Vedanta Biosciences appoints former Genzyme VP chief scientific officer

March 16, 2016 Medical Communications, Research and Development Bruce Roberts, Genzyme, Vedanta Biosciences

Vedanta Biosciences, a company developing therapies designed to modulate the human microbiome, has appointed former Genzyme group vice president, Bruce …
Appointment
vascepa

COMMENT: What does Amarin’s off-patent victory over the FDA mean for the industry?

March 14, 2016 Medical Communications, Sales and Marketing Amarin, FDA, off label, off-label, vascepa

Last week, Pharmafile.com reported that small biopharma Amarin had settled litigation with US drugs regulator the FDA that will allow …
Feature

MSF challenges Pfizer’s pneumonia vaccine patent in India

March 11, 2016 Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine

The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …
News
grifolslogo

Spanish firm Grifols to spend a total of $360 million on four new plants

March 11, 2016 Manufacturing and Production, Medical Communications grifols, manufacturing, pharma, plasma, production

Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …
News
facilities_lg06

Dr. Reddy’s, TR-Pharm to collaborate on 3 biosimilars in Turkey

March 11, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Dr Reddy's Laboratories, TR-Pharm, biosimilar, generics, marketing collaboration

Three biosimilar products by the Indian generics company Dr. Reddy’s will be marketed by TR-Pharm in Turkey, the companies said …
News
spark_logo

Spark Therapeutics buys Genable Tech for $6 million in cash and stock deal

March 11, 2016 Business Services, Medical Communications Genable Technologies, Spark Therapeutics, cash & stock, genetic technologies, merger & acquisitions

Spark Therapeutics (Nasdaq: ONCE) said it has acquired Ireland-based Genable Technologies, a privately-held gene therapy firm for $6 million in a cash …
News
shutterstock_38078521

US FDA sets April 25 date to review Sarepta’s DMD drug, shares jump

March 11, 2016 Medical Communications, Research and Development Duchenne Muscular Dystrophy, Eteplirsen, Sarepta Therapeutics, US FDA

Shares in US-based Sarepta Therapeutics (Nasdaq: SRPT) jumped nearly 15% Thursday after the US Food and Drug Administration (FDA) said it …
News
valeant_sign

US Congress Committee pressures Valeant to produce drug pricing documents

March 11, 2016 Medical Communications, Sales and Marketing Drug pricing, Michael Pearson, Valeant

Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …
News
vials_purple_liquid

Alphabet’s life science unit makes device to aid gathering of health data for research

March 11, 2016 Medical Communications, Research and Development Alphabet, Connectivity Bridge, Verily, google, life sciences

Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for …
News
sanofi_logo_on_building

Sanofi says its RA drug bested Humira in Phase III study

March 11, 2016 Medical Communications, Research and Development Humira, Regeneron, Sanofi

Sanofi and its R&D arm Regeneron Pharmaceuticals say their monoclonal antibody sarilumab outperformed AbbVie’s Humira in treating the symptoms of …
News
shutterstock_212432119

Vericel stock nearly doubles as heart failure drug meets primary endpoint in mid-stage trial

March 11, 2016 Medical Communications, Research and Development

Shares in US-based biotech firm Vericel nearly doubled on the Nasdaq on Thursday as the company reported its heart failure …
News
fougera

Novartis to unify Fougera’s US manufacturing plants

March 11, 2016 Manufacturing and Production, Medical Communications Fougera, Novartis, Sandoz, manufacturing

Novartis is planning to unify the two manufacturing plants used by Sandoz unit Fougera Pharmaceuticals in the US, expanding and …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

Two-drug combo shown to significantly shrink breast cancer in days

March 10, 2016 Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb

Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …
News
msd_sanat_chattopadhyay_

New manufacturing boss for MSD

March 10, 2016 Manufacturing and Production, Medical Communications MSD, manufacturing

MSD has appointed Sanat Chattopadhyay president of the Merck Manufacturing Division (MMD) and an executive vice president of the company. …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025